Perrigo Announces FDA Approval Of The AB Rated Generic Version Of KlorCon® Extended-Release Tablets
Go back to Perrigo Announces FDA Approval Of The AB Rated Generic Version Of KlorCon® Extended-Release Tablets| Perrigo (NYSE: PRGO) | Delayed: 16.37 +0.46 (2.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.91 | 52 Week High | $156.03 | |||
| Open | $15.99 | 52 Week Low | $79.72 | |||
| Day High | $16.45 | P/E | N/A | |||
| Day Low | $15.90 | EPS | $0.00 | |||
| Volume | 1,782,777 | |||||
| Perrigo (NYSE: PRGO) | Delayed: 16.37 +0.46 (2.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.91 | 52 Week High | $156.03 | |||
| Open | $15.99 | 52 Week Low | $79.72 | |||
| Day High | $16.45 | P/E | N/A | |||
| Day Low | $15.90 | EPS | $0.00 | |||
| Volume | 1,782,777 | |||||



